|
End-of-day quote
Korea S.E.
23/09/2026
|
5-day change | 1st Jan Change | ||
| 7,190.00 KRW | -1.10% |
|
-3.49% | -55.89% |
| 05-19 | TegoScience Inc. agreed to acquire 95.77% stake in PNP Pharm Co., Ltd. for KRW 3.7 billion. | CI |
| 27/05/25 | TegoScience Inc. announced that it has received KRW 27 billion in funding | CI |
| Market Cap | 57.57B 42.41M 37.21M 35.15M 32.03M 59.96M 4.06B 60.38M 421M 163M 2.08B 159M 156M 6.67B | P/E 2024 |
29.9x | P/E 2025 | -18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 22.28B 16.42M 14.4M 13.6M 12.4M 23.21M 1.57B 23.37M 163M 63.05M 804M 61.63M 60.3M 2.58B | EV / Sales 2024 |
11x | EV / Sales 2025 | 16x |
| Free-Float |
51.46% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.10% | ||
| 1 week | -3.49% | ||
| Current month | -4.13% | ||
| 1 month | -5.15% | ||
| 3 months | +10.45% | ||
| 6 months | -43.43% | ||
| Current year | -55.89% |
| 1 week | 7,000 |  | 7,860 |
| 1 month | 7,000 | | 9,100 |
| Current year | 5,230 | | 16,500 |
| 1 year | 5,230 | | 18,800 |
| 3 years | 5,230 | | 26,100 |
| 5 years | 5,230 | | 27,450 |
| 10 years | 5,230 | | 73,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sae-Wha Jeon
CEO | Chief Executive Officer | 60 | 20/03/2001 |
Han-Kyu Jang
PRN | Corporate Officer/Principal | 53 | - |
Sung-In Chung
AUD | Comptroller/Controller/Auditor | 66 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sae-Wha Jeon
BRD | Director/Board Member | 60 | 20/03/2001 |
Jae-Wook Jeon
BRD | Director/Board Member | 63 | 20/03/2001 |
Han-Kyu Jang
BRD | Director/Board Member | 53 | 01/05/2001 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.10% | -3.49% | -60.69% | -16.40% | 42.41M | |
| +2.08% | +29.11% | +712.09% | +102.69% | 79.4B | |
| -1.00% | +0.41% | +39.75% | -5.33% | 78.69B | |
| -1.21% | +0.77% | -8.90% | -30.77% | 59.52B | |
| +1.18% | +3.03% | +8.89% | +167.27% | 46.58B | |
| -1.80% | -2.29% | -11.16% | +30.65% | 46.53B | |
| +0.55% | +5.61% | +65.68% | -11.80% | 33.63B | |
| -0.44% | -1.13% | +49.81% | +108.99% | 25.11B | |
| -0.10% | +3.21% | +6.92% | +160.99% | 22.13B | |
| +0.05% | -2.42% | +60.01% | +97.55% | 15.31B | |
| Average | -0.18% | +3.10% | +86.24% | +60.39% | 40.69B | |
| Weighted average by Cap. | -0.02% | +6.45% | +156.20% | +55.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.76B 4.98M 4.37M 4.13M 3.76M 7.04M 477M 7.09M 49.38M 19.13M 244M 18.69M 18.29M 784M | 5.94B 4.38M 3.84M 3.63M 3.31M 6.19M 419M 6.23M 43.4M 16.81M 214M 16.43M 16.08M 689M |
| Net income | 3.35B 2.47M 2.17M 2.05M 1.86M 3.49M 237M 3.51M 24.47M 9.48M 121M 9.26M 9.06M 388M | -7.01B -5.17M -4.53M -4.28M -3.9M -7.3M -495M -7.36M -51.23M -19.84M -253M -19.4M -18.98M -813M |
| Net Debt | -25.58B -18.85M -16.54M -15.62M -14.23M -26.64M -1.81B -26.83M -187M -72.39M -923M -70.76M -69.23M -2.97B | -35.28B -25.99M -22.81M -21.54M -19.63M -36.75M -2.49B -37.01M -258M -99.84M -1.27B -97.59M -95.48M -4.09B |
Employees
39
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/09/26 | ₩7,190.00 | -1.10% | 8,391 |
| 22/09/26 | ₩7,270.00 | +0.14% | 1,816 |
| 21/09/26 | ₩7,260.00 | -2.55% | 4,775 |
| 18/09/26 | ₩7,450.00 | -1.97% | 3,588 |
- Stock Market
- Stocks
- A191420 Stock
Select your edition
All financial news and data tailored to specific country editions
